233 related articles for article (PubMed ID: 36125881)
1. Cell-free DNA topology depends on its subcellular and cellular origins in cancer.
Malkin EZ; De Michino S; Lambie M; Gill R; Zhao Z; Rostami A; Arruda A; Minden MD; Bratman SV
JCI Insight; 2022 Oct; 7(20):. PubMed ID: 36125881
[TBL] [Abstract][Full Text] [Related]
2. Mutation detection of urinary cell-free DNA via catch-and-release isolation on nanowires for liquid biopsy.
Takahashi H; Yasui T; Hirano M; Shinjo K; Miyazaki Y; Shinoda W; Hasegawa T; Natsume A; Kitano Y; Ida M; Zhang M; Shimada T; Paisrisarn P; Zhu Z; Ohka F; Aoki K; Rahong S; Nagashima K; Yanagida T; Baba Y
Biosens Bioelectron; 2023 Aug; 234():115318. PubMed ID: 37172361
[TBL] [Abstract][Full Text] [Related]
3. Liquid biopsy using the supernatant of a pleural effusion for EGFR genotyping in pulmonary adenocarcinoma patients: a comparison between cell-free DNA and extracellular vesicle-derived DNA.
Lee JS; Hur JY; Kim IA; Kim HJ; Choi CM; Lee JC; Kim WS; Lee KY
BMC Cancer; 2018 Dec; 18(1):1236. PubMed ID: 30526536
[TBL] [Abstract][Full Text] [Related]
4. Saliva-based cell-free DNA and cell-free mitochondrial DNA in head and neck cancers have promising screening and early detection role.
Sayal L; Hamadah O; Almasri A; Idrees M; Thomson P; Kujan O
J Oral Pathol Med; 2023 Jan; 52(1):29-36. PubMed ID: 36459078
[TBL] [Abstract][Full Text] [Related]
5. Extracellular Vesicle-Derived DNA vs. CfDNA as a Biomarker for the Detection of Colon Cancer.
Thakur K; Singh MS; Feldstein-Davydova S; Hannes V; Hershkovitz D; Tsuriel S
Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440345
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic impact of cell-free DNA in human cancers: Systematic review.
Cervena K; Vodicka P; Vymetalkova V
Mutat Res Rev Mutat Res; 2019; 781():100-129. PubMed ID: 31416571
[TBL] [Abstract][Full Text] [Related]
7. Cell Free DNA as an Evolving Liquid Biopsy Biomarker for Initial Diagnosis and Therapeutic Nursing in Cancer- An Evolving Aspect in Medical Biotechnology.
Ray SK; Mukherjee S
Curr Pharm Biotechnol; 2022; 23(1):112-122. PubMed ID: 33308128
[TBL] [Abstract][Full Text] [Related]
8. Limitations and opportunities of technologies for the analysis of cell-free DNA in cancer diagnostics.
Song P; Wu LR; Yan YH; Zhang JX; Chu T; Kwong LN; Patel AA; Zhang DY
Nat Biomed Eng; 2022 Mar; 6(3):232-245. PubMed ID: 35102279
[TBL] [Abstract][Full Text] [Related]
9. Size distribution of cell-free DNA in oncology.
Udomruk S; Orrapin S; Pruksakorn D; Chaiyawat P
Crit Rev Oncol Hematol; 2021 Oct; 166():103455. PubMed ID: 34464717
[TBL] [Abstract][Full Text] [Related]
10. Extracellular vesicles as a potential source of tumor-derived DNA in advanced pancreatic cancer.
Lapin M; Tjensvoll K; Nedrebø K; Taksdal E; Janssen H; Gilje B; Nordgård O
PLoS One; 2023; 18(9):e0291623. PubMed ID: 37708210
[TBL] [Abstract][Full Text] [Related]
11. Extracellular Vesicles: A Brief Overview and Its Role in Precision Medicine.
Shang M; Ji JS; Song C; Gao BJ; Jin JG; Kuo WP; Kang H
Methods Mol Biol; 2017; 1660():1-14. PubMed ID: 28828643
[TBL] [Abstract][Full Text] [Related]
12. Bile cell‑free DNA as a novel and powerful liquid biopsy for detecting somatic variants in biliary tract cancer.
Shen N; Zhang D; Yin L; Qiu Y; Liu J; Yu W; Fu X; Zhu B; Xu X; Duan A; Chen Z; Wang X; Cao X; Zhao T; Zhou Z; Yu L; Qin H; Fang Z; Li JY; Liu Y; Xiong L; Yuan B; Li F; Zhang Y
Oncol Rep; 2019 Aug; 42(2):549-560. PubMed ID: 31173267
[TBL] [Abstract][Full Text] [Related]
13. Deep cfDNA fragment end profiling enables cancer detection.
Zhitnyuk YV; Koval AP; Alferov AA; Shtykova YA; Mamedov IZ; Kushlinskii NE; Chudakov DM; Shcherbo DS
Mol Cancer; 2022 Jan; 21(1):26. PubMed ID: 35062943
[No Abstract] [Full Text] [Related]
14. Liquid biopsy and their application progress in head and neck cancer: focus on biomarkers CTCs, cfDNA, ctDNA and EVs.
Meng Y; Bian L; Zhang M; Bo F; Lu X; Li D
Biomark Med; 2020 Oct; 14(14):1393-1404. PubMed ID: 33073579
[TBL] [Abstract][Full Text] [Related]
15. Kinetics and Topology of DNA Associated with Circulating Extracellular Vesicles Released during Exercise.
Neuberger EWI; Hillen B; Mayr K; Simon P; Krämer-Albers EM; Brahmer A
Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33918465
[TBL] [Abstract][Full Text] [Related]
16. Genetic Profiling of Cell-Free DNA From Pleural Effusion in Advanced Lung Cancer as a Surrogate for Tumor Tissue and Revealed Additional Clinical Actionable Targets.
Tu HY; Li YS; Bai XY; Sun YL; Zheng MY; Ke EE; Liao RQ; Jiang BY; Lin JX; Huang J; Xu BF; Yang JJ; Zhang XC; Zhou Q; Wang BC; Chen HJ; Tong X; Yu R; Wu X; Zhu D; Wu YL
Clin Lung Cancer; 2022 Mar; 23(2):135-142. PubMed ID: 34645582
[TBL] [Abstract][Full Text] [Related]
17. Towards effectiveness of cell free DNA based liquid biopsy in head and neck squamous cell carcinoma.
Kowal-Wisniewska E; Jaskiewicz K; Bartochowska A; Kiwerska K; Ustaszewski A; Gorecki T; Giefing M; Paluszczak J; Wierzbicka M; Jarmuz-Szymczak M
Sci Rep; 2024 Jan; 14(1):2251. PubMed ID: 38278927
[TBL] [Abstract][Full Text] [Related]
18. Extraction of urinary cell-free DNA by using triamine-modified silica particles for liquid biopsy.
Kato M; Fujita Y; Iizuka T; Nozaki K; Takano S; Funatsu T; Sano Y; Murayama S; Karasawa K
Anal Bioanal Chem; 2020 Sep; 412(23):5647-5652. PubMed ID: 32613569
[TBL] [Abstract][Full Text] [Related]
19. 'Longing' for the Next Generation of Liquid Biopsy: The Diagnostic Potential of Long Cell-Free DNA in Oncology and Prenatal Testing.
Yu SCY; Choy LYL; Lo YMD
Mol Diagn Ther; 2023 Sep; 27(5):563-571. PubMed ID: 37474843
[TBL] [Abstract][Full Text] [Related]
20. Non-blood sources of cell-free DNA for cancer molecular profiling in clinical pathology and oncology.
Ponti G; Manfredini M; Tomasi A
Crit Rev Oncol Hematol; 2019 Sep; 141():36-42. PubMed ID: 31212145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
